Corvia
formerly Corvia MedicalTreatment for Symptomatic Heart Failure | Corvia® Atrial Shunt
Tewksbury, United States · Founded 2009 · $90.0M raised
- Headquarters
- Tewksbury, Massachusetts
- Employees
- 11–50
- Founded
- 2009
- Business Model
- B2B
- Website
- corviamedical.com
- Total Funding
- $90.0M
- Last Round
- $35.0M Series DJun 2025
- Rounds
- 2
About
Develops the Corvia Atrial Shunt, a transcatheter implant for HFpEF and HFmrEF, used by hospitals to reduce left atrial pressure.
Summary
Corvia is a Life Sciences company based in Tewksbury, United States, founded in 2009. It has raised $90.0M in total across 2 rounds, most recently a $35.0M Series D round in Jun 2025. Investors include J.P. Morgan Life Sciences Private Capital, General Catalyst and Third Rock Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
Zipline delivers vital shipments via the most reliable drone delivery service in the world.
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.